GBA1 and Parkinson disease: It is yet to be established whether the slower decline rate in DAT signal in GBA1-PD subjects is caused by the compensatory upregulation of tracer uptake in the early stage of the disease or disruption of dopamine release preceding dopaminergic terminal loss [110,111].